- Home
- CLSD vs RDZN Comparison
CLSD vs RDZN Comparison
Compare CLSD & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- RDZN
- Stock Information
- Founded
- CLSD 2011
- RDZN 2015
- Country
- CLSD United States
- RDZN United States
- Employees
- CLSD N/A
- RDZN N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- RDZN Blank Checks
- Sector
- CLSD Health Care
- RDZN Finance
- Exchange
- CLSD Nasdaq
- RDZN Nasdaq
- Market Cap
- CLSD 69.0M
- RDZN 79.4M
- IPO Year
- CLSD 2016
- RDZN N/A
- Fundamental
- Price
- CLSD $0.76
- RDZN $0.98
- Analyst Decision
- CLSD Strong Buy
- RDZN Strong Buy
- Analyst Count
- CLSD 5
- RDZN 2
- Target Price
- CLSD $4.80
- RDZN $5.00
- AVG Volume (30 Days)
- CLSD 161.6K
- RDZN 322.3K
- Earning Date
- CLSD 05-14-2025
- RDZN 07-01-2025
- Dividend Yield
- CLSD N/A
- RDZN N/A
- EPS Growth
- CLSD N/A
- RDZN N/A
- EPS
- CLSD N/A
- RDZN N/A
- Revenue
- CLSD $3,764,000.00
- RDZN $42,893,256.00
- Revenue This Year
- CLSD N/A
- RDZN $4.52
- Revenue Next Year
- CLSD $476.77
- RDZN $53.72
- P/E Ratio
- CLSD N/A
- RDZN N/A
- Revenue Growth
- CLSD N/A
- RDZN 2.79
- 52 Week Low
- CLSD $0.70
- RDZN $0.68
- 52 Week High
- CLSD $1.65
- RDZN $3.28
- Technical
- Relative Strength Index (RSI)
- CLSD 34.26
- RDZN 51.05
- Support Level
- CLSD $0.77
- RDZN $0.87
- Resistance Level
- CLSD $0.91
- RDZN $1.18
- Average True Range (ATR)
- CLSD 0.06
- RDZN 0.16
- MACD
- CLSD -0.01
- RDZN 0.01
- Stochastic Oscillator
- CLSD 5.82
- RDZN 39.38
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.